UK jobs. Bigger possibilities.

Clinical Project Manager in Neuropsychopharmacology and Experimental Medicine

Hybrid in London·Part-time·Added today (last checked 28 Oct)

Imperial College London

88 open roles

Apply

Our summary

Work mode: Hybrid, London
Contract: Part-time
Closing date: Apply by Tuesday 24 November

Skills

Requirements

What we're looking for

You should have experience in the coordination or management of biomedical or clinical research studies (preferably within a university, NHS, or research organisation setting). You should have experience of clinical research delivery and strong organisational skills. You must be able to build effective working relationships with a wide range of stakeholders, and have an understanding of Patient and Public Involvement and Engagement (PPIE) in clinical research.

The role

We are looking to recruit a Clinical Project Manager to run an exciting Medical Research Council (MRC)-funded Experimental Medicine study, "N,N-Dimethyltryptamine (DMT) for Disorders of Consciousness (DoC)" (DMT-DoC). In people with DoC, this study will investigate the effects of intravenous DMT administration on measures of neural complexity, neuroplasticity, and awareness.

You will primarily be working to deliver the DMT-DoC study. This placebo-controlled study involves administering intravenous DMT and a saline placebo to patients with DoC. We will record electroencephalography (EEG) alongside other physiological and behavioural measures before, during, and after drug/placebo administration.

You will work in the Computational Neurology group of academic neurologist Dr Gregory Scott, within the Department of Brain Sciences, with a team of collaborators including experts in clinical neurology, psychedelics, neuropsychopharmacology, DoC, EEG, computer science, and neurophysiology.

This is an exciting opportunity to work on a study that could pave the way to a new class of treatment for DoC and improve our understanding of the neural mechanisms of consciousness.

What you'll do

You will be responsible for all aspects of study management. This will include involvement and coordination of study set-up, in close liaison with Dr Scott. You will lead on the development of study documentation, regulatory submissions, monitoring progress and performance of the study and recruitment from participant identification centres, ensuring efficient recruitment and reliable data collection. This will be achieved through implementing / adapting established procedures to ensure the studies are conducted in accordance with contractual agreements, study protocol, study-specific processes and systems, SOPs, regulatory and ethical requirements and ICH-GCP guidelines, as well as delivered to time and within budget constraints. You will liaise closely with the participant-facing staff, including the Research Assistant, Post-doctoral Research Associate, trial medics, and psychedelics and brain injury specialists. You will also support the coordination of patient and public involvement and engagement (PPIE) and study monitoring activities, and attracting further research funding to the group.

What we can offer you

A unique opportunity to work on an exciting experimental study
Join a highly multi-disciplinary group in a world-leading institution

Further information

This is a part-time (50% FTE), fixed term post until 31 March 2030. You will be based principally at the Hammersmith and White City Campuses, in Dr Scott's group, and will be expected to spend 60% of your time on-site in line with Imperial's Work Location framework.

You will be expected to travel between sites, and also potentially to collaborating research sites, e.g., The Royal Hospital for Neurodisability, Putney.

Should you require any further details on the role please contact: Dr Gregory Scott (gregory.scott99@imperial.ac.uk)